# Equity Bancshares Inc: financial statements, quarterly

EQBK · NYSE · CIK 1227500 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqbk.md) · [Financials](/companies/eqbk/financials.md) · [Filings](/companies/eqbk/filings.md) · [Insiders](/companies/eqbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eqbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [24.0](/filings/0000950170-24-124190.md) | [24.8 d](/filings/0001193125-26-100184.md) | [27.6](/filings/0000950170-25-068091.md) | [28.7](/filings/0001193125-25-177050.md) | [28.9](/filings/0001193125-25-262699.md) | [25.5 d](/filings/0001193125-26-100184.md) | [24.4](/filings/0001193125-26-214751.md) | [24.4](/filings/0001193125-26-340292.md) | [28.6](/filings/0001193125-25-262699.md) | [27.4 d](/filings/0001193125-26-100184.md) | [34.4](/filings/0001193125-26-214751.md) | [34.0](/filings/0001193125-26-340292.md) |
| Income tax | $m | [1.9](/filings/0000950170-24-124190.md) | [(11.4) d](/filings/0001193125-26-100184.md) | [3.7](/filings/0000950170-25-068091.md) | [4.6](/filings/0001193125-25-177050.md) | [4.0](/filings/0001193125-25-262699.md) | [3.4 d](/filings/0001193125-26-100184.md) | [3.8](/filings/0001193125-26-214751.md) | [3.1](/filings/0001193125-26-340292.md) | [(7.6)](/filings/0001193125-25-262699.md) | [4.4 d](/filings/0001193125-26-100184.md) | [5.3](/filings/0001193125-26-214751.md) | [7.3](/filings/0001193125-26-340292.md) |
| Net income | $m | [12.3](/filings/0000950170-24-124190.md) | [(28.3) d](/filings/0001193125-26-100184.md) | [14.1](/filings/0000950170-25-068091.md) | [11.7](/filings/0001193125-25-177050.md) | [19.9](/filings/0001193125-25-262699.md) | [17.0 d](/filings/0001193125-26-100184.md) | [15.0](/filings/0001193125-26-214751.md) | [15.3](/filings/0001193125-26-340292.md) | [(29.7)](/filings/0001193125-25-262699.md) | [22.1 d](/filings/0001193125-26-100184.md) | [17.0](/filings/0001193125-26-214751.md) | [26.4](/filings/0001193125-26-340292.md) |
| Diluted EPS | $ per share | [0.80](/filings/0000950170-24-124190.md) | not reported | [0.90](/filings/0000950170-25-068091.md) | [0.76](/filings/0001193125-25-177050.md) | [1.28](/filings/0001193125-25-262699.md) | not reported | [0.85](/filings/0001193125-26-214751.md) | [0.86](/filings/0001193125-26-340292.md) | [(1.55)](/filings/0001193125-25-262699.md) | not reported | [0.80](/filings/0001193125-26-214751.md) | [1.27](/filings/0001193125-26-340292.md) |
| Basic EPS | $ per share | [0.80](/filings/0000950170-24-124190.md) | not reported | [0.91](/filings/0000950170-25-068091.md) | [0.77](/filings/0001193125-25-177050.md) | [1.30](/filings/0001193125-25-262699.md) | not reported | [0.86](/filings/0001193125-26-214751.md) | [0.87](/filings/0001193125-26-340292.md) | [(1.55)](/filings/0001193125-25-262699.md) | not reported | [0.81](/filings/0001193125-26-214751.md) | [1.28](/filings/0001193125-26-340292.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [4,945](/filings/0000950170-23-062178.md) | [5,035](/filings/0000950170-25-035585.md) | [5,239](/filings/0000950170-24-057178.md) | [5,246](/filings/0000950170-24-094841.md) | [5,355](/filings/0000950170-24-124190.md) | [5,332](/filings/0001193125-26-100184.md) | [5,446](/filings/0000950170-25-068091.md) | [5,374](/filings/0001193125-25-177050.md) | [6,366](/filings/0001193125-25-262699.md) | [6,373](/filings/0001193125-26-340292.md) | [7,667](/filings/0001193125-26-214751.md) | [7,726](/filings/0001193125-26-340292.md) |
| Total liabilities | $m | [4,527](/filings/0000950170-23-062178.md) | [4,582](/filings/0000950170-25-035585.md) | [4,782](/filings/0000950170-24-057178.md) | [4,784](/filings/0000950170-24-094841.md) | [4,851](/filings/0000950170-24-124190.md) | [4,739](/filings/0001193125-26-100184.md) | [4,829](/filings/0000950170-25-068091.md) | [4,738](/filings/0001193125-25-177050.md) | [5,654](/filings/0001193125-25-262699.md) | [5,641](/filings/0001193125-26-340292.md) | [6,850](/filings/0001193125-26-214751.md) | [6,898](/filings/0001193125-26-340292.md) |
| Long-term debt | $m | [383](/filings/0000950170-23-062178.md) | [387](/filings/0000950170-24-028081.md) | [367](/filings/0000950170-24-057178.md) | [392](/filings/0000950170-24-094841.md) | [438](/filings/0000950170-24-124190.md) | [313](/filings/0000950170-25-035585.md) | [377](/filings/0000950170-25-068091.md) | [448](/filings/0001193125-25-177050.md) | [487](/filings/0001193125-25-262699.md) | [443](/filings/0001193125-26-100184.md) | [490](/filings/0001193125-26-214751.md) | [533](/filings/0001193125-26-340292.md) |
| Shareholders' equity | $m | [418](/filings/0000950170-24-124190.md) | [453](/filings/0001193125-26-100184.md) | [457](/filings/0001193125-25-177050.md) | [461](/filings/0001193125-25-262699.md) | [504](/filings/0001193125-25-262699.md) | [593](/filings/0001193125-26-340292.md) | [617](/filings/0001193125-26-340292.md) | [636](/filings/0001193125-26-340292.md) | [712](/filings/0001193125-25-262699.md) | [732](/filings/0001193125-26-340292.md) | [818](/filings/0001193125-26-340292.md) | [827](/filings/0001193125-26-340292.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.1 d](/filings/0000950170-24-124190.md) | [13.0 d](/filings/0001193125-26-100184.md) | [12.6](/filings/0000950170-25-068091.md) | [16.0 d](/filings/0001193125-25-177050.md) | [23.5 d](/filings/0001193125-25-262699.md) | [21.7 d](/filings/0001193125-26-100184.md) | [21.7](/filings/0001193125-26-214751.md) | [28.3 d](/filings/0001193125-26-340292.md) | [8.5 d](/filings/0001193125-25-262699.md) | [(7.1) d](/filings/0001193125-26-100184.md) | [15.3](/filings/0001193125-26-214751.md) | [38.8 d](/filings/0001193125-26-340292.md) |
| Capital expenditure | $m | [5.2 d](/filings/0000950170-24-124190.md) | [3.4 d](/filings/0001193125-26-100184.md) | [2.0](/filings/0000950170-25-068091.md) | [0.8 d](/filings/0001193125-25-177050.md) | [3.8 d](/filings/0001193125-25-262699.md) | [1.8 d](/filings/0001193125-26-100184.md) | [1.5](/filings/0001193125-26-214751.md) | [2.3 d](/filings/0001193125-26-340292.md) | [4.0 d](/filings/0001193125-25-262699.md) | [5.5 d](/filings/0001193125-26-100184.md) | [3.8](/filings/0001193125-26-214751.md) | [3.3 d](/filings/0001193125-26-340292.md) |
| Dividends paid | $m | [1.5 d](/filings/0000950170-24-124190.md) | [1.9 d](/filings/0001193125-26-100184.md) | [1.9](/filings/0000950170-25-068091.md) | [1.8 d](/filings/0001193125-25-177050.md) | [1.9 d](/filings/0001193125-25-262699.md) | [2.3 d](/filings/0001193125-26-100184.md) | [2.7](/filings/0001193125-26-214751.md) | [2.6 d](/filings/0001193125-26-340292.md) | [2.6 d](/filings/0001193125-25-262699.md) | [3.4 d](/filings/0001193125-26-100184.md) | [3.5](/filings/0001193125-26-214751.md) | [3.7 d](/filings/0001193125-26-340292.md) |
| Share repurchases | $m | [(0.1) d](/filings/0000950170-24-124190.md) | [0.3 d](/filings/0001193125-26-100184.md) | [6.8](/filings/0000950170-25-068091.md) | [5.1 d](/filings/0001193125-25-177050.md) | [0.0 d](/filings/0001193125-25-262699.md) | [0.0 d](/filings/0001193125-26-100184.md) | [0.0](/filings/0001193125-26-214751.md) | [0.3 d](/filings/0001193125-26-340292.md) | [6.5 d](/filings/0001193125-25-262699.md) | [7.2 d](/filings/0001193125-26-100184.md) | [22.7](/filings/0001193125-26-214751.md) | [9.9 d](/filings/0001193125-26-340292.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.3](/filings/0000950170-23-062178.md) | [16.0](/filings/0000950170-24-057178.md) | [15.6](/filings/0000950170-24-094841.md) | [15.5](/filings/0000950170-24-124190.md) | [15.6](/filings/0000950170-25-068091.md) | [15.4](/filings/0001193125-25-177050.md) | [15.5](/filings/0001193125-25-262699.md) | [17.7](/filings/0001193125-26-214751.md) | [17.7](/filings/0001193125-26-340292.md) | [19.1](/filings/0001193125-25-262699.md) | [21.3](/filings/0001193125-26-214751.md) | [20.8](/filings/0001193125-26-340292.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 20,592,490 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340292.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.